LB780 Randomized, Blind, Placebo-Controlled Clinical Trial on the Clinical Efficacy of Oclacitinib, an Oral Janus Kinase Inhibitor, in a Canine Model of Spontaneously Occurring Atopic Dermatitis
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2016.05.030
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Elsevier BV